Invesco Ltd. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 52 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$26,345
-9.6%
10,094
-24.5%
0.00%
Q1 2023$29,158
-76.5%
13,375
-6.9%
0.00%
Q1 2022$124,000
-33.3%
14,370
+10.6%
0.00%
Q4 2021$186,000
-98.9%
12,991
-98.3%
0.00%
-100.0%
Q3 2021$16,599,000
+10678.6%
755,195
+6478.4%
0.00%
Q2 2021$154,00011,4800.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 8,355$61,0000.04%
TOCQUEVILLE ASSET MANAGEMENT L.P. 70,000$508,0000.01%
Financial Architects, Inc 2,000$15,0000.00%
FineMark National Bank & Trust 3,473$25,0000.00%
JFS WEALTH ADVISORS, LLC 1,000$7,0000.00%
Penserra Capital Management LLC 2,540$18,0000.00%
Tower Research Capital LLC (TRC) 1,284$10,0000.00%
SIMPLEX TRADING, LLC 2,673$19,0000.00%
Plante Moran Financial Advisors, LLC 300$2,0000.00%
Cutler Group LLC / CA 2,404$17,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders